Clinical Review
Safety and Effectiveness of Topical Anesthetics in Corneal Abrasions: Systematic Review and Meta-Analysis

https://doi.org/10.1016/j.jemermed.2015.02.051Get rights and content

Abstract

Background

Topical anesthetics are used in the emergency department (ED) to relieve eye pain and allow eye examinations in patients with corneal abrasions. There is concern for delayed corneal healing, which is associated with the long-term use of topical anesthetics, so outpatient use is not recommended.

Objectives

We sought to systematically study the effectiveness and complications associated with the short-term use of topical anesthetics (≤72 hours) in the management of patients presenting to EDs with corneal abrasions.

Methods

Four electronic databases were searched from inception of the database until April 2014. We included studies of patients >16 years of age who were using topical anesthetics for <72 hours. Postoperative cases were not included.

Results

A total of 140 patients (68 in the intervention group and 72 in the control group) from 2 randomized trials were included in the analysis. Comparing control patients who did not use topical anesthetics to study patients who did use topical anesthetics, this meta-analysis found no significant difference in pain scores (standardized mean difference −1.01 [95% confidence interval {CI} −2.39 to 0.38), corneal healing (OR 1.31 [95% CI 0.53–3.27), or persistent symptoms (OR 0.98 [95% CI 0.06–16.69). The 2 trials reported no adverse effects.

Conclusion

There were no differences regarding pain, persistent symptoms, or corneal healing when comparing short-term use of topical anesthetics to placebo in the treatment of corneal abrasion. Data on safety are sparse, and the use of this treatment is currently not supported by evidence.

Introduction

Corneal abrasions are one of the most common complaints presenting to primary care and emergency departments (EDs) in the United States and worldwide, and represent the leading cause of red eye in EDs 1, 2, 3, 4. Corneal abrasion is defined as a disruption of the epithelium covering the cornea, and it is commonly caused by minor trauma, foreign bodies, contact lens use, and flash burns (5).

Although corneal abrasion is in general a self-limited benign entity, it can be the cause of discomfort, pain, and distress among patients and can lead to work absenteeism 4, 6. Although common in EDs, there is considerable variation in the clinical management approaches to corneal abrasions, including the use of oral analgesic, cycloplegic, and topical nonsteroidal antiinflammatory drugs (7).

Topical anesthetics traditionally have been used for pain management of corneal abrasions while the patient is in the ED; its use for outpatient analgesia has been discouraged because of the concern of delayed corneal healing that has been shown with its long-term use (8). However, the evidence supporting these concerns is mostly out of date and based on case reports. At the same time, the short-term use of topical anesthetics (<72 hours) in the acute setting is debated (9). Available research about short-term use is derived from studies reporting no complications after use of local anesthetics after photorefractive keratectomy and after corneal abrasions managed in EDs 10, 11, 12, 13, 14.

Withholding what appears to be a potentially appropriate therapy for pain associated with corneal abrasion leads to the use of other analgesics that may be not as effective and may even have more complications (9). The objectives of this systematic review are to study the effectiveness and potential complications of the use of topical anesthetics in the management of patients presenting to EDs with corneal abrasions.

Section snippets

Methods

This systematic review and meta-analysis is reported in accordance with recommendations from the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement (15). The review protocol was developed in April 2014 and was followed during the entire review.

Study Selection

The study selection process is shown in Figure 1.

Study Characteristics

The total number of individuals included in the review was 140 (68 in the intervention group and 72 in the control group), with a mean age of 37 years (range 17–74 years). Women accounted for 14% of the subjects. One type of drug was used in the studies, with 2 different concentrations and administration schedules. Control patients were given saline drops. Patients from all groups were given the same instructions regarding frequency and method of

Discussion

Our extensive literature search was able to identify 2 studies reporting the use of topical anesthetics in corneal abrasions for a period of <72 hours. This timeframe was selected because corneal abrasions without complications should be healed before 72 hours (18).

This review includes a total of 140 patients in 2 studies 12, 13. We found no difference between topical anesthetic use and placebo in the outcomes of pain, persistent symptoms, and corneal healing. In 1 trial, there was a perception

Conclusion

In the treatment of corneal abrasion, evidence that warrants low confidence showed no difference between topical anesthetics and placebo in terms of pain, persistent symptoms, and corneal healing. Assessment of safety is not possible with the available evidence. The use of topical anesthetics in the management of pain associated with corneal abrasion is currently not supported by evidence.

Article Summary

1. Why is this topic important?

  1. Corneal abrasion is a common complaint in patients presenting to primary care physicians and emergency

Acknowledgments

H.A.P. is a recipient of a scholarship from CAPES Foundation, Ministry of Education of Brazil, Brasilia - DF, 70.040-020, through the Brazil Scientific Mobility Program. M.F.B. is a Scholar in the Robert D. and Patricia E. Kern Center for the Sciences of the Health Care Delivery at Mayo Clinic. We thank Tobias Kummer, md, and Larshan Perinpam, bsc, for their help in the translation of foreign language articles.

References (31)

  • J.W. Ufberg et al.

    Dogma challenged: tetracaine for corneal abrasions?

    Acad Emerg Med

    (2014)
  • S. Verma et al.

    A comparative study of the duration and efficacy of tetracaine 1% and bupivacaine 0.75% in controlling pain following photorefractive keratectomy (PRK)

    Eur J Ophthalmol

    (1997)
  • N. Waldman et al.

    Topical tetracaine used for 24 hours is safe and rated highly effective by patients for the treatment of pain caused by corneal abrasions: a double-blind, randomized clinical trial

    Acad Emerg Med

    (2014)
  • J.Y. Ting et al.

    Management of Ocular Trauma in Emergency (MOTE) trial: a pilot randomized double-blinded trial comparing topical amethocaine with saline in the outpatient management of corneal trauma

    J Emerg Trauma Shock

    (2009)
  • I.M. Ball et al.

    Dilute proparacaine for the management of acute corneal injuries in the emergency department

    CJEM

    (2010)
  • Cited by (14)

    • The two-faced effects of nerves and neuropeptides in corneal diseases

      2022, Progress in Retinal and Eye Research
      Citation Excerpt :

      Topical anesthetics are particularly effective, but their chronic use is associated with toxic keratopathy, corneal melting and perforation, which make their safety profile unacceptable (Chen et al., 2004; Wu et al., 2016; Rao et al., 2007; Sugar, 1998). Moreover, corneal pain in patients treated with topical anesthetics does not seem to be significantly reduced when compared with placebo (Puls et al., 2015). Topical NSAIDs have also been proposed for the treatment of corneal pain.

    • An Observational Study to Determine Whether Routinely Sending Patients Home With a 24-Hour Supply of Topical Tetracaine From the Emergency Department for Simple Corneal Abrasion Pain Is Potentially Safe

      2018, Annals of Emergency Medicine
      Citation Excerpt :

      Swaminathan et al47 concluded that topical anesthetics are a safe and effective means of pain control in this patient population. However, Puls et al48 concluded that because of a sparsity of data, the safety and effectiveness of this treatment is currently not supported by evidence. The most recent suggestion that thoughts on the topic are changing came in the 2015 edition of Emergency Medicine Secrets, stating that “…consensus is evolving regarding short-course therapy for uncomplicated corneal abrasions.”5

    • Ophthalmologic Emergencies: Assessment and Management

      2023, Advanced Emergency Nursing Journal
    View all citing articles on Scopus

    Reprints are not available from the authors.

    View full text